Polyamine concentration (nmol/mg protein) B Control SSAT SPDS SPMS siRNA - + + - + + - + + - + + Doxycycline Control si ODC kDa - - + - - + - - + - - + Doxorubicin kDa 0 4 8 0 4 8 Doxorubicin (Hrs): 58 58 DNp73β DNp73 46 30 Egfp Actin odc ssat RT-PCR gapdh spds spms gapdh C D Polyamine concentration (nmol/mg protein) H1299 HCT116 kDa 0 2 4 6 Doxorubicin (Hrs): 58 DNp73β 46 Actin paox gapdh Supplementary Figure 1 Bunjobpol et al.
Supplementary Figure 2 Bunjobpol et al. C Vector FosB mutant paox RLU kDa 0 1.5 3 4.5 0 1.5 3 4.5 CHX (Hrs) 58 DNp73β 46 FosB 30 46 Actin % DNp73 remaining Time after cycloheximide (Hrs) B D 0 2 4 6 0 2 4 6 Vector c-Jun CHX (Hrs) Actin DNp73β siRNA % DNp73 remaining Time after cycloheximide (Hrs) JunB Actin DNp73β 0 1.5 3 4.5 0 1.5 3 4.5 Vector CHX (Hrs) Time after cycloheximide (Hrs) % DNp73 remaining kDa kDa 58 58 30 30 46 46 Supplementary Figure 2 Bunjobpol et al.
(% vector control knockdown ) A B FosB c-Jun az1 Actin gapdh Vector Control si Az1 DNp73β (% vector control knockdown ) DNp73β/Actin Vector c-Jun FosB Control Az1 siRNA kDa kDa Az1 (p) Actin 0 200 300 μM MDL 72527 58 17 30 46 46 30 46 Supplementary Figure 3 Bunjobpol et al.
Normailzed paox expression units Thyroid Thyroid B-cell leukemia Prostate Gastric 3 2 2 2.5 2 1 1 1.5 Normailzed paox expression units 1.5 1 -2.5 Normal (n=4) Tumour (n=14) Normal (n=9) Tumour (n=9) Normal (n=74) Tumour (n=147) Normal (n=8) Tumour (n=13) Normal (n=31) Tumour (n=4) Oncomine boxed plots B kDa DNp73β Actin SHSY5Y DNp73β 0 50 100 150 200 250 μM MDL 72527 58 46 Supplementary Figure 4 Bunjobpol et al.
Supplementary Figure 5 Bunjobpol et al. SHSY5Y pcDNA SHSY5Y DNp73β +MDL 0 0.25 0.5 0 0.25 0.5 Vector DNp73β SHSY5Y μM Doxorubicin + MDL 72527 - MDL 72527 Propidium Iodide Annexin V - FITC B C SHSY5Y pcDNA SHSY5Y DNp73β +MDL Caspase3 activity ΔOD400nm pcDNA DNp73β kDa 58 DNp73 Actin HCT116 46 D CDDP Control sipaox DNp73β HCT116 Vector - + - + Propidium Iodide Annexin V - FITC HCT116 pcDNA HCT116 DNp73β Control sipaox % Ann. V+/PI+ Supplementary Figure 5 Bunjobpol et al.